Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages.
The nonenzymatic glycation of LDL is a naturally occurring chemical modification of apolipoprotein (apo)-B lysine residues by glucose. Once glycated, LDL is only poorly recognized by lipoprotein receptors including the LDL receptor (LDL-R), the LDL-R-related protein (LRP), and scavenger receptors. Glycated LDL (gLDL) is a preferred target for oxidative modifications. Additionally, its presence initiates different processes that can be considered "proatherogenic." Thus, LDL glycation might contribute to the increased atherosclerotic risk of patients with diabetes and familial hypercholesterolemia. Here we investigate whether lipoprotein lipase (LPL) can mediate the cellular uptake of gLDL. The addition of exogenous LPL to the culture medium of human skin fibroblasts, porcine aortic endothelial cells, and mouse peritoneal macrophages enhanced the binding, uptake, and degradation of gLDL markedly, and the relative effect of LPL on lipoprotein uptake increased with the degree of apoB glycation. The efficient uptake of gLDL by LDL-R-deficient fibroblasts and LRP-deficient Chinese hamster ovary cells in the presence of LPL suggested a mechanism that was independent of the LDL-R and LRP. In macrophages, the uptake of gLDL was also correlated with their ability to produce LPL endogenously. Mouse peritoneal macrophages from genetically modified mice, which lacked LPL, exhibited a 75% reduction of gLDL uptake compared with normal macrophages. The LPL-mediated effect required the association of the enzyme with cell surface glycosaminoglycans but was independent of its enzymatic activity. The uptake of gLDL in different cell types by an LPL-mediated process might have important implications for the cellular response after gLDL exposure as well as the removal of gLDL from the circulation.
Zimmermann
R
R
Institute of Molecular Biology, Biochemistry and Microbiology, SFB-Biomembranes Research Center, Karl-Franzens-University, Graz Heinrichstrasse 31a, A-8010 Graz, Austria.
Panzenböck
U
U
Wintersperger
A
A
Levak-Frank
S
S
Graier
W
W
Glatter
O
O
Fritz
G
G
Kostner
G M
GM
Zechner
R
R
D000107:Acetylation; D000818:Animals; D016466:CHO Cells; D002460:Cell Line; D006224:Cricetinae; D004730:Endothelium, Vascular / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism*; D017127:Glycation End Products, Advanced; D006801:Humans; D008027:Light; D008071:Lipoprotein Lipase / Q000378:metabolism*; D008077:Lipoproteins, LDL / Q000493:pharmacokinetics*; D008264:Macrophages / Q000378:metabolism*; D011973:Receptors, LDL / Q000378:metabolism; D012542:Scattering, Radiation; D015854:Up-Regulation; D000093844:Glycated Proteins
D017127:Glycation End Products, Advanced; D008071:Lipoprotein Lipase; D008077:Lipoproteins, LDL; D011973:Receptors, LDL; C031797:glycated lipoproteins, LDL; D000093844:Glycated Proteins